Carregant...

New direct-acting antivirals in the development for hepatitis C virus infection

A large number of new therapies are in development for chronic hepatitis C including direct-acting antiviral drugs (DAA), which target specific hepatitis C virus enzymes. Two of these compounds have already advanced into phase 3 development in the USA and EU, and many more are in phase 2 trials and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Pockros, Paul J.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3002578/
https://ncbi.nlm.nih.gov/pubmed/21180601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X10363055
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!